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Arginine-rich cell-penetrating peptides have found excellent utility in cell and in vivo models for enhancement
of delivery of attached charge-neutral PNA or PMO oligonucleotides. We report the synthesis of dendrimeric
peptides containing 2- or 4-branched arms each having one or more R-Ahx-R motifs and their disulﬁde conjugation
to a PNA705 splice-redirecting oligonucleotide. Conjugates were assayed in a HeLa pLuc705 cell assay for
luciferase up-regulation and splicing redirection. Whereas 8-Arg branched peptide-PNA conjugates showed poor
activity compared to a linear (R-Ahx-R)4-PNA conjugate, 2-branched and some 4-branched 12 and 16 Arg
peptide-PNA conjugates showed activity similar to that of the corresponding linear peptide-PNA conjugates.
Many of the 12- and 16-Arg conjugates retained signiﬁcant activity in the presence of serum. Evidence showed
that biological activity in HeLa pLuc705 cells of the PNA conjugates of branched and linear (R-Ahx-R) peptides
is associated with an energy-dependent uptake pathway, predominantly clathrin-dependent, but also with some
caveolae dependence.
INTRODUCTION
Cell-penetrating peptides (CPPs) have proven extremely
valuable for enhancing the cell delivery of a range of biomol-
ecules either as covalent conjugates or as noncovalent com-
plexing agents (1). Among the biocargoes that are well-suited
for CPP conjugation are antisense oligonucleotide (ON) ana-
logues that are used to target RNAs inside cells (2, 3). Par-
ticularly good results have been obtained in cell delivery when
CPPs are conjugated to charge-neutral peptide nucleic acid
(PNA) and phosphorodiamidate morpholino oligonucleotides
(PMO) that are used for non-RNase-H steric block antisense
applications (4, 5). Such ON analogues are metabolically stable
inside cells and in tissues, and retain very good sequence
speciﬁcity in binding to RNA targets. Peptide conjugates of PNA
and PMO are now being investigated in therapeutic applications,
for example, for redirecting RNA splicing in diseases such as
Duchenne muscular dystrophy (DMD) (6, 7).
A wide range of CPPs has been proposed for PNA and PMO
conjugation, some of which are derived from small transduction
domains of proteins (Tat (48-60), Penetratin), and many others
are composite or synthetically designed (2, 3). Most CPPs are
cationic, and often, they also contain regions of hydrophobic
amino acids. Cationic charge helps the binding of the CPP to
the cell surface glycosaminoglycans. However, the mechanisms
of cell uptake following cell surface binding are diverse and in
some cases have proven controversial. It is commonly recog-
nized that in most cases at modest concentrations (1 µM or less)
and, especially when conjugated to an ON cargo, endocytotic
uptake mechanisms of CPPs predominate, rather than direct
translocation (2, 3). Cationic and hydrophobic elements in the
CPP are also thought to help to enhance their release from
endosomes into the cytosol, but the exact spatial parameters
for optimal release are not well understood.
It has become well accepted that when viewed by live-cell
confocal microscopy ﬂuorescently tagged cationic CPP-ON
conjugates usually become sequestered within endosomal
compartments (8). However, to interact with mRNA or pre-
mRNA targets, ONs must reach the cytosol or nucleus,
respectively. In order to better understand what parameters
within an attached CPP are required to help endosomal release
and thus allow the attached ON to reach its RNA target, it is
necessary to utilize a biological assay that is characteristic of
the cell compartment. Kole and colleagues developed such an
assay for the nucleus, whereby HeLa cells contain an integrated
pLuc705 plasmid coding for a ﬁreﬂy luciferase gene within
which is embedded an aberrant  -globin intron. To produce
ﬁreﬂy luciferase, it is necessary to deliver into the nucleus of
the HeLa cells an 18-mer synthetic ON (which is targeted to
the 705 site) to restore correct splicing of the pre-mRNA and
hence a functional luciferase mRNA (9). This assay is straight-
forward and has a high dynamic range, which allows both high
and low activity levels to be measured quantitatively as a
positive luminescence readout. In addition, the EC50 of the
splicing redirection can be assessed readily at the RNA level
by an RT-PCR assay.
By use of the HeLa pLuc705 assay, we have reported that
Arg-rich peptides are particularly valuable as delivery agents
into cells when covalently conjugated to PNA or PMO ON
cargoes in the absence of any transfection or other delivery
agent. For example, we found that (R-Ahx-R)4-PNA705 and
(R-Ahx-R)4-PMO705 conjugates (Ahx ) aminohexanoic acid)
were able to redirect splicing more efﬁciently than conjugates
of Tat, Penetratin, or oligo-Arg classical CPPs (10-12). The
interspersing of the non-natural Ahx amino acids is advanta-
geous in providing an optimal spatial distribution of guanidinium
side chains, in increasing metabolic stability, and in decreasing
cytotoxicity (13, 14).
Further, the active fraction of such conjugates appears to enter
HeLa pLuc705 cells predominantly by energy-dependent en-
docytosis (10), similarly to that found previously for PNA con-
jugates of Tat peptide (15). In addition, Arg-rich conjugates of
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muscle cell delivery and exon skipping in a mdx mouse model
of Duchenne muscular dystrophy (DMD), and such conjugates
are in preclinical development (6). Other candidate Arg-rich
peptides (such as Pip peptides and B-MSP) also utilize R-Ahx-R
or R- -R (  ) beta-alanyl) motifs and have been used
successfully to deliver PMO with even higher activity in mdx
mice (16, 17).
We described recently a synthetic, Arg-rich tetramerizing
peptide R10p53tet where ten Arg residues were added to the
N-terminus of the well-deﬁned tetramerization domain of p53
protein (18). The peptide was conjugated close to its C-terminus
to the PNA705 18-mer used in splice-redirecting studies. The
splicing redirection efﬁciency of the PNA705 when added to
HeLa pLuc705 cells was found to be much greater for the
R10p53tet conjugate than for R10p53mono, a point mutant in the
p53 domain that had been shown previously to be unable to
tetramerize. The R10p53tet-PNA705 conjugate was more active
than any of the conjugates to CPPs previously tested by us in
this assay, such as Tat (12, 19), Penetratin (19), R6-Penetratin
(19), and Pip2b (16). However, the R10p53tet peptide was long
(50 amino acids) and the synthetic yields were not high, and
therefore, this paradigm does not seem likely to be readily
adaptable for in vivo studies. Nevertheless, the principle of
multivalency seemed to be highly beneﬁcial as originally sug-
gested (20).
Several years ago, Futaki and colleagues reported branched-
chain arginine peptides where 4 or 8 short oligo-Arg chains
were constructed based on chain branching through both the R
and ε positions of Lys residues (21). The best translocation into
HeLa cells was observed when the Arg residues were inter-
spersed with three Gly residues (RG3R) and placed on a four-
armed structure, resulting in a branched 8-arginine conﬁguration.
This branched peptide was conjugated either directly to ﬂuo-
rescein or to the protein carbonic anhydrase labeled with
ﬂuorescein, and the translocation was visualized by confocal
microscopy. Unfortunately, at that time confocal microscopy
was carried out in the presence of a cell ﬁxative (acetone/
methanol), conditions now known to result in artifactual cell
uptake and intracellular redistribution of cationic peptides (8).
More recently, 4-branched RG3R peptides with an Alexa
ﬂuorescent dye attached were shown to locate in endosomal
compartments using live-cell imaging (22). However, no activity
data for any attached cargo were reported.
Another recent development has been the use of a synthetic
dendrimer where eight guanidine moieties were arranged to
branch from a central triazine core by means of hexyl spacers
(23). When attached to PMO oligonucleotides, the octa-gua-
nidino dendrimer was able to enhance cell delivery of the PMO
in cultured cells in the presence of serum and also enhance
delivery in vivo in a wide range of tissues (23, 24). These
conjugates are sold commercially as “Vivo-morpholinos”. Thus,
the concept of spacing arginine (or guanidine) moieties in a
three-dimensional dendrimer conﬁguration seemed worth ex-
ploring further.
We now describe straightforward solid-phase techniques for
the chemical synthesis of 2- and 4-branched Arg-rich peptide
dendrimers where such branches contain multiple (R-Ahx-R)
motifs. Such branched peptides were conjugated to a charge-
neutral PNA705 cargo and evaluated for their splice-redirecting
activity in a HeLa pLuc705 system in comparison to equivalent
linear peptides. Whereas 8-Arg branched peptide-PNA con-
jugates showed poor activity compared to linear peptide-PNA
conjugate, 2-branched and some 4-branched 12 and 16 Arg
peptide-PNA conjugates showed activities similar to those of
the corresponding linear peptide-PNA conjugates. Many of the
12- and 16-Arg conjugates retained signiﬁcant activity in the
presence of serum. Evidence was shown that biological activity
of the peptide-PNA in HeLa cells is associated primarily with
an energy-dependent uptake pathway, predominantly clathrin-
dependent, but that caveolae can also play a role.
EXPERIMENTAL PROCEDURES
Synthesis of Linear and Branched (R-Ahx-R)-Containing
Peptides. Peptide syntheses were carried out using a CEM
Liberty microwave peptide synthesizer by Fmoc chemistry.
Linear peptides were synthesized starting with 100 µmol of
functionalized Fmoc-PAL-PEG-PS solid support (Applied Bio-
systems), 2-branched peptides were synthesized starting with
50 µmol of support, and 4-branched peptides starting with 25
µmol of support. For all branched peptide syntheses, each Fmoc
amino acid derivative was made up to the same concentration
as if it was a standard 100 µmol-scale linear synthesis. Thus,
for a 2-branched peptide, the excess activated Fmoc amino acid
over growing chains in the coupling reactions after the chain
branching step was 10-fold, and for a 4-branch peptide, the
excess after two branching steps was 5-fold. Coupling reactions
were carried out using Fmoc-amino acids in DMF activated with
0.99 equiv of PyBop in DMF and 1.98 equiv of diisopropyl-
ethylamine (DIPEA) in N-methylpyrrolidone (NMP). The branch
point amino acid derivative was Fmoc-Lys(Fmoc)-OH (Nova-
biochem). Fmoc-Arg(Pbf)-OH (Novabiochem) was used for Arg
couplings with the microwave double-coupling protocol previously
reported (25). Fmoc-deprotection at each cycle was carried out
using 20% piperidine in DMF containing 0.1 M hydroxybenzot-
riazole (HOBT). The ﬁnal peptidyl resin was washed with DMF
and then dichloromethane and dried in vacuo.
Cleavage and deprotection were carried out using TFA/water/
ethanedithiol/triethylsilane (94:2.5:2.5:1, 20 mL) for 2 h, the
resin removed by ﬁltration and washed with TFA (ca. 5 mL)
and the ﬁltrate sparged with nitrogen to obtain a small volume.
The peptide was precipitated by addition of cold diethyl ether,
collected by centrifugation, and the pellet washed a further 5
times with cold ether (25 mL).
Preparative HPLC was carried out using a Phenomenex
Jupiter 10 µ C18 column (250 × 10 mm): buffer A, 0.1% TFA
in water; buffer B, acetonitrile containing 10% buffer A. Elution
was with a linear gradient of 15-50% buffer B over 25 min.
Detection was at 215/230 nm (diode array) with a ﬂow rate of
3.5 mL min-1. Analytical HPLC used the same column type (5
µ, 250 × 4.6 mm) and similar buffer and 10-40% B over 25
min gradient conditions (1.5 mL min-1). Representative HPLC
traces for branched peptides are shown in Supporting Informa-
tion Figure 1. MALDI-TOF mass spectral analysis used a
Voyager DE Pro BioSpectrometry workstation with a matrix
of R-cyano-4-hydroxycinnamic acid, 10 mg mL-1 in acetoni-
trile-0.1% aqueous TFA (1:1 v/v). The accuracy of mass mea-
surement is regarded as (0.05%.
PNA Synthesis. NH2-Cys(NPys)-Lys-CCTCTTACCTCAGT-
TACA-Lys-amide (PNA705) was synthesized by the Fmoc/Bhoc
method using PNA monomers obtained from Link Technologies
Ltd. (Lanarkshire, Scotland) on a Liberty microwave peptide syn-
thesizer, puriﬁed by HPLC, and characterized by MALDI-TOF
mass spectrometry as previously described (16, 18, 26).
Conjugation of Peptides to PNA705. Disulﬁde conjugation
between the single Cys residue on the peptide component and
the single NPys-Cys residue on the PNA705 was carried out
essentially as described previously using a 2.5-fold excess of
peptide over PNA705 (16, 19, 27). Puriﬁcation of conjugates
by reversed-phase HPLC was carried out using buffers identical
to those used for peptide puriﬁcation and linear gradients, with
diode array monitoring at 215 and 260 nm. Products were
obtained by lyophilization of desired HPLC fractions. Repre-
sentative examples of peptide-PNA conjugate crude and puri-
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All conjugates were characterized by MALDI-TOF mass
spectrometry as described previously (16, 19, 27).
Cell Culture and Splicing Redirection Assays. This was
carried out similarly to that described previously (16, 19, 27).
Peptide-PNA conjugates were incubated for4hi n0.35 mL
OptiMEM medium with exponentially growing HeLa pLuc705
cells (1.25 × 105 cells/well seeded and cultivated overnight in
24 well plates). The medium was removed, 1 mL complete
medium (DMEM plus 10% fetal bovine serum) was added, and
incubation continued for 20 h. Cells were washed twice with
ice-cold PBS and lysed with Reporter Lysis Buffer (Promega,
Madison, WI). Luciferase activity was quantiﬁed with a Berthold
Centro LB 960 luminometer (Berthold Technologies, Bad
Wildbad, Germany) using the Luciferase Assay System substrate
(Promega, Madison, WI). Cellular protein concentrations were
measured with the BCA Protein Assay Kit (Pierce, Rockford,
IL) and read using an ELISA plate reader (Dynatech MR 5000,
Dynatech Laboratories, Chantilly, VA) at 550 nm. Levels of
luciferase expression are shown as relative luminescence units
(RLU) per microgram of protein or as fold increase in lumi-
nescence over background. All experiments were carried out
in triplicate. Each data point was averaged over the three
replicates.
For dose-dependence experiments, cells were treated as
described above with increasing concentrations of conjugates.
After carrying out the luciferase assay and BCA Protein Assay,
the remaining cell lysates (about 270 µL) were transferred into
2 mL microfuge tubes, and total RNA was extracted with 1
mL TRI Reagent (Sigma). Minor changes to the manufacturer’s
protocol were made to accommodate the presence of Reporter
Lysis Buffer. Thus, 0.3 mL of chloroform was used for
extraction, and the amount of isopropanol for RNA precipitation
was increased to give a 1:1 mixture with the aqueous phase.
The extracted RNA was examined by RT-PCR (SuperScript III
One-Step RT PCR with Platinum Taq, Invitrogen; Genius
Techne Thermal cycler) with forward primer 5′-TTG ATA TGT
GGA TTT CGA GTC GTC-3′ and reverse primer 5′-TGT CAA
TCA GAG TGC TTT TGG CG-3′. The products were analyzed
on a 2% agarose gel, which was scanned using Gene Tools
Analysis Software (SynGene, Cambridge, UK).
Cell Culture and Splicing Redirection Assays at Low
Temperature. This was carried out as described previously
(18, 19). HeLa pLuc705 cells were preincubated for 30 min in
OptiMEM at 37 or 4 °C. The conjugate was then added and
incubation continued for 1 h before assay for luciferase activity
was measured as above.
Cell Culture and Splicing Redirection in the Presence
of Endocytosis Inhibitors. This was carried out similarly to
the method described previously (19). HeLa pLuc705 cells were
preincubated in OptiMEM at 37 °C for 20 min with one of the
following inhibitors: chlorpromazine (30 µM), methyl- -cyclo-
dextrin (MBCD) (2.5 mM), nystatin (50 µM), or ammonium
chloride (50 mM). Cells were washed twice with PBS and
incubated in OptiMEM with the same concentrations of the
inhibitors in the presence of 1 µM of peptide-PNA conjugate
at 37 °C for 30 min. Cells were washed twice with PBS, 1 mL
of DMEM complete medium was added, and incubation
continued for 23 h. Each experiment was in triplicate. Luciferase
expression was quantiﬁed as described above. At these con-
centrations of inhibitors and under the incubation conditions
used, good cell viability was obtained in all cases (data not
shown).
RESULTS
Synthesis of PNA705 Conjugates of Linear and Branched
(R-Ahx-R)-Containing Peptides. Although the concept of chain
branching through R and ε positions of Lys via use of Fmoc
Lys(Fmoc)-OH was described ﬁrst by Futaki (21), there were
a number of signiﬁcant differences in our methodology. First,
we introduced proteolysis resistant Arg-Ahx-Arg (RXR) units
as repeating units instead of oligo-Arg or Arg-(Gly)3-Arg units.
Second, we used the proteolysis resistant Ahx- Ala (X ) spacer
between the branches and the C-terminal Cys residue used for
conjugation to cargo, and we also varied the spacing within
branches by addition of further X or   units. Third, we in-
vestigated 2-branched as well as 4-branched structures. Finally,
we attached a PNA cargo via a disulﬁde bond and used the
well-known HeLa pLuc705 cell reporter assay that is a measure
of the ability of the peptide dendrimer structure to deliver the
Table 1. List of Branched and Linear Peptides Synthesized and
their EC50 Values in the RT-PCR Assay in the HeLa pLuc705 Cells
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with branched analogues containing the same number of Arg
residues, starting with 8-Arg residues (R-Ahx-R)4 and increasing
the numbers of Arg residues to 12 and 16. The dendrimer
structures and linear peptides RXR4, RXR6 and RXR8 are
shown in Table 1.
Synthesis of branched peptide dendrimers (Figure 1A) was
carried out very conveniently by microwave-aided solid-phase
synthesis using the Fmoc method with a different solid support
and different activation agent than reported by Futaki et al. (21).
The coupling reactions were all very efﬁcient, and only single
couplings were needed except for Arg residues. It should be
noted that we took account of the need to maintain at least a
5-fold excess of amino acids over solid-support-bound growing
chains in coupling reactions at all times by reduction of the
amount of solid support for 2- and 4-branched syntheses (see
Experimental Procedures). The high yields and efﬁcient syn-
theses are demonstrated by the HPLC traces obtained for the
crude products of synthesis (Supporting Information Figure 1,
showing representative 4- and 2-branched dendrimer peptide
crude and puriﬁed products and MALDI-TOF analysis). Note
that it was not necessary to use 5% pyridine/DMF solvent and
extended (21 h) coupling times in the FmocArg(Pbf)-OH
coupling reactions as previously reported (21). Instead, the use
of microwave heating and a double coupling protocol proved
highly effective (25).
Conjugation of puriﬁed branched and linear peptides to PNA
was carried out through disulﬁde bond by reaction of each
C-terminal Cys-containing peptide with the N-terminal Cys(N-
Pys) PNA705 18-mer sequence (Figure 1B) as previously
described for other linear cell-penetrating peptides (16, 18, 19, 27).
Highly efﬁcient conjugations were obtained with only small
amounts of unconjugated peptide and PNA remaining (Sup-
porting Information Figure 2 shows representative HPLCs for
crude products and puriﬁed conjugates for RXR8-4B1-PNA705
and RXR8-2B-PNA705). Note that a disulﬁde linkage has the
Figure 1. (A) Scheme of solid-phase peptide synthesis of branched peptides RXR4-4B1 and RXR4-2B as representative examples of the strategy
of synthesis via branching with Fmoc-Lys (Fmoc)-OH and arms of R-Ahx-R units. Reagents and resin are as described in the Experimental
section. (B) Scheme of the disulﬁde conjugation method used where the PNA contains a NPys-Cys functionality and the peptide a C-terminal free
Cys functionality.
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peptide vector once inside cells because of the reducing envi-
ronment, as we have used for our previous R10p53tet dendrimer
system (18).
Splice-Redirection Activity of Linear and Branched Pep-
tide-PNA Conjugates. We reported previously the splice-
redirection activity of linear (RXR)4-PNA and linear (RXR)4-
PMO conjugates in the HeLa pLuc705 cell assay (10, 12).
Although signiﬁcantly better than (Lys)8, Tat (48-60), Pen-
etratin, and oligoArg conjugates (12, 19, 28), EC50 values using
an RT-PCR assay for the amount of splice-redirected mRNA
remained in the micromolar range. To our knowledge, splice-
redirection of PNA conjugates to peptide containing a larger
number of Arg residues has not been reported previously. We
found that for the linear (R-Ahx-R) peptides an increase in the
number of Arg residues to 12 (RXR6-PNA705) resulted in a
signiﬁcantly more active conjugate in the luciferase up-
regulation assay than RXR4-PNA705, with a further increase
in activity for 16 Arg residues (RXR8-PNA705) (Figure 2a).
EC50 values (Table 1) were determined from the RT-PCR assay
by scanning of the agarose gel electrophoregrams (Figure 2b).
The biggest improvement in activity was between RXR4 (EC50
> 3 µM) and RXR6 (1.0 ( 0.1 µM), whereas a more modest
improvement was seen for RXR8 (0.8 ( 0.1 µM).
PNA705 conjugates of 4-branched constructs of RXR4 where
each arm contained a single RXR (RXR4-4B1), or a single
RXRX (RXR4-4B2), or where additional X spacing was
included between the ﬁrst and second branch points (RXR4-
4B3), or a 2-branch analogue with RXRRXR on each branch
(RXR4-2B) all showed a dramatic loss of splice-redirecting
activity, such that even at 3 µM concentration the luciferase
expression activity was barely above background (Figure 3A).
Likewise, a 4-branched structure containing four RXRRX  arms
(RXR6-4B) had very poor activity (Figure 3B, Table 1). By
contrast, for PNA705 conjugates of RXR6 branched analogues,
a 2-branched structure containing arms of RXRRXRRXR
(RXR6-2B) gave rise to luciferase expression levels only a
little lower than that of the linear RXR6 (Figure 3B, Table 1).
The PNA705 conjugate of RXR8 2-branched analogue
(RXR8-2B) showed luciferase expression levels very similar
to that for the linear RXR8 (Figure 3C), whereas the 4-branched
RXR8 analogues (RXR8-4B1 and RXR8-4B2) were only
slightly reduced in activity compared to the linear RXR8 (Figure
3C). The EC50 values (Table 1) for splice-redirected RNA
measured by the RT-PCR assay in general reﬂected the same
trends as for luciferase up-regulation results, with values for
PNA705 conjugates of 2-branched peptides with 12 and 16
residues being very similar to their linear counterparts. Overall,
chain branching appears to be best tolerated when the number
of Arg residues is 16. For both 12 and 16 Arg residues, 2-
branched structures are more active than 4-branched structures
and are similar to their linear counterparts in activity. None of
the 12 and 16 Arg residue conjugates showed signiﬁcant toxicity,
and the cell viability remained good in an MTS assay up to 3
µM with HeLa pLuc705 cells (Figure 4).
We also carried out the same luciferase and RT-PCR assays
for RXR8-4B-PNA705, RXR8-2B-PNA705, and RXR8-
PNA705 using a human melanoma tumor cell line containing
the same integrated pLuc705 plasmid, namely, A375SM-
Luc705-B cells (29). The results were broadly similar to the
Figure 2. (A) Fold increase in luciferase expression induced by splicing redirection by incubation of RXR4-PNA705, RXR6-PNA705, and RXR8-
PNA705 with HeLa pLuc705 cells. Concentrations of conjugates in each case (left to right) are 0.4, 0.6. 0.8. 1.2, and 1.8 µM. (B) RT-PCR analysis
showing aberrant and redirected levels of RNA as a function of concentrations of RXR6-PNA705 or RXR8-PNA705. Concentrations of conjugates
(left to right) are the same as in (A), namely, 0.4, 0.6, 0.8, 1.2, and 1.8 µM. NT ) cells not treated.
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the EC50 values in the RT-PCR assay were lower than for the
HeLa cells (RXR8-4B1, 0.51 ( 0.03 µM; RXR8-2B, 0.35 (
0.02 µM; RXR8, 0.42 ( 0.05 µM), probably reﬂecting a lower
copy number of integrated pLuc705 plasmid in the melanoma
cell line, but cell viability dropped signiﬁcantly at 1 µM and
higher concentrations for all these peptide-PNA conjugates
(data not shown).
In addition, we carried out the HeLa pLuc705 cell luciferase
assays at 1.2 µM concentration for4hi nt h epresence of 10%
fetal bovine serum (FBS). Interestingly, in most cases for 12
Arg and 16 Arg conjugates of PNA705 there was signiﬁcant
activity retained in the presence of serum, compared to serum-
free media, especially for the 2-branched and the linear
constructs (Supporting Information Figure 3). This is in contrast
to unbranched peptide-PNA conjugates containing fewer Arg
residues such as RXR4-PNA and R6Pen-PNA, where we had
previously found very poor activity in the presence of serum
(Arzumanov, A., Abes, R., Gait, M. J., and Lebleu, B., unpub-
lished data).
Thus, we also synthesized a 25-mer PMO conjugate of
RXR8-2B targeted to exon 23 of a mutated mouse dystrophin
gene by the method previously described (16). At 1 µM
concentration of incubation with differentiated mdx mouse cells
in the presence of 10% FBS, but in the absence of any
transfection agent, we were able to obtain >70% exon skipping
in this model system, higher than for previously studied linear
RXR peptide-PMO constructs (data not shown). This demon-
strates that there are potential advantages of a higher number
of Arg residues in the peptides in terms of activity levels in the
presence of serum, which could be crucial for clinical applications.
Mechanism of Cell Uptake in HeLa pLuc705 Cells. The
internalization mechanism of CPPs has been questioned ever
since the ﬁrst peptides were discovered. Initially, the consensus
in the ﬁeld was for direct translocation across the plasma
membrane, but nowadays, endocytosis is considered the major
pathway for many CPPs at low concentrations (2). We thus felt
it necessary to determine whether increased biological activity
of our branched peptide conjugates in comparison with the linear
forms could be due to the use of a different cell uptake route.
We ﬁrst examined the splicing redirection activity of these
peptide conjugates at low temperature of 4 °C (conditions
preventing any form of endocytosis) and physiological temper-
ature 37 °C. Cells were preincubated at 4 or 37 °C during 30
min and then incubated with the different branched peptide
conjugates at 1 µM during1ha t4o r3 7°C. The results showed
a decrease of the activity at low temperature, suggesting that
the internalization of the branched peptide conjugates is
predominantly energy dependent (Figure 5).
Likewise, controversies remain concerning the endocytotic
pathway used for the cell internalization pathway of CPP-cargo
conjugates with data advocating all three major routes (2, 3).
We thus investigated the effects of typical inhibitors of clathrin-
dependent, caveolae-dependent, and macropinocytosis pathways,
Figure 3. Fold increase in luciferase expression induced by splicing redirection in HeLa pLuc705 cells over the conjugate concentration range
0.6-3.0 µM: (A) branched and linear RXR4-PNA705 derivatives, (B) branched and linear RXR6-PNA705 derivatives, and (C) branched RXR8-
PNA705 derivatives (inset shows a comparison of RXR8-2B-PNA705 and linear RXR8-PNA705 over a different concentration range 0.3-1.2
µM).
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(MBCD), respectively. The importance of acidiﬁcation of
endocytotic vesicles was evaluated with NH4Cl. For these ex-
periments, incubation times were reduced in order to avoid
cytotoxicity of the inhibitors. Interestingly, splicing redirection
efﬁciency by branched CPPs remained unchanged when reduc-
ing the incubation time to 30 min as compared to the 4 h
incubations generally used in our studies. This is very different
from the situation observed with RXR4-PMO conjugate, for
example (data not shown).
Nystatin addition resulted in some reduction in the biological
activity of both linear and branched peptides (Figure 6). Since
nystatin complexes cholesterol and alters the structure and
function of glycolipid microdomains, caveolae seem to be
involved. Somewhat surprisingly, the activity increased using
methyl- -cyclodextrin, suggesting that branched peptides may
Figure 4. Percentage cell viability for branched and linear peptide-PNA705 conjugates as measured by the MTS assay. To each well of cells treated
for 4 h with 0.6, 1.8, or 3.0 µM conjugate in OptiMEM (100 µL, 96 well plate) was added 20 µL of CellTiter 96 Aqueous One solution cell
proliferation assay (Promega) and the color intensity measured by plate reader (Tecan, Switzerland) at 490 nm as compared to a control of cells
which were not treated with conjugate. Experiments were carried out in triplicate.
Figure 5. Low-temperature study (37 and 4 °C). Cells were preincubated at 37 °C (white bars) or 4 °C (gray bars) for 1 h and further incubated
in the same conditions with PNA705 conjugates of RXR4, RXR6, RXR8, RXR8-4B1, or RXR8-2B, peptides conjugates at 1 µM. Luciferase
expression assays were carried out after 24 h as indicated in the Experimental Procedures. Experiments were made in triplicate, and error bars are
indicated. Data are expressed as the percentage of luciferase activity.
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cytoplasm when the membrane cholesterol is depleted, as
previously reported for oligoArg (30). By contrast, chlorpro-
mazine exerted a very strong effect on the biological activity
with almost 90% decrease for RXR8-2B-PNA and RXR8-
4B1-PNA (Figure 6). Together, these data support the notion
that the clathrin-dependent uptake pathway is prominently and
preferentially involved in the internalization of the branched
peptides, as has already been documented for linear RXR4-
PMO (11), Pip peptide-PNA conjugates (16), and Tat peptide
(15), but with some caveolae dependence also.
Cells were also treated with NH4Cl, which is known to
neutralize the acidiﬁcation of endosomal and lysosomal com-
partments (31). NH4Cl (50 mM) caused a strong reduction in
the splicing redirection activity of both linear and branched
peptides with 16 Arg residues suggesting there is an accumula-
tion in acidic compartment as shown previously for Tat-PNA
conjugates (15) and a requirement for endosomal acidiﬁcation
for endosomal escape (Figure 6).
DISCUSSION
Synthesis of branched dendrimer peptides using R-Ahx-R
repeating units proved very straightforward by the use of
microwave-aided Fmoc solid-phase synthesis techniques. Indeed,
the number of coupling steps in branched peptide syntheses is
less than that for the equivalent linear peptide syntheses
containing the same number of Arg residues, and the HPLC
traces of the crude products all showed very high overall yields
(Supporting Information Figure 1). Disulﬁde conjugations to
PNA were just as effective as for linear peptides (Supporting
Information Figure 2).
The use of a HeLa pLuc705 splice-redirecting assay for
assessment of CPPs is particularly valuable to judge delivery
efﬁcacy because of its convenience, large dynamic range and
its ability to measure activity in the cell nucleus for attached
PNA or PMO through assays at both the RNA and protein
expression levels. In our opinion, a functional assay of this type
is superior to the use of ﬂuorescent labels and observation of
cell localization by confocal microscopy, because it is a true
measure of the ability of a cargo to be delivered in a biologically
relevant way, in this case to the cell nucleus. Thus, despite the
apparently promising results of Futaki et al. for a 4-branched
RG3R peptide with 8-Arg residues in total where substantial
cell uptake of the peptide was observed when a ﬂuorescent label
was attached (21, 22), by contrast, we found extremely poor
luciferase up-regulation in the HeLa cell assay for PNA705
conjugates of both 2-branched and 4-branched peptide with only
8 Arg residues and much poorer than the linear RXR4-PNA.
This suggests that branching the 8 Arg residues in this way
does not trigger sufﬁcient endosomal escape of the PNA cargo
and represents a good example of how following the uptake of
ﬂuorescently labeled peptides by confocal microscopy is not
predictive of subsequent biological function. We already
observed a lack of correlation between cell uptake and biological
activity in our SAR studies of a series of linear RXR-PMO
conjugates (13).
As the number of Arg residues is increased to 12 and 16,
however, not only does the overall level of luciferase up-
regulation and splicing correction increase signiﬁcantly with the
number of Arg residues, but chain branching is now increasingly
tolerated (Figures 2 and 3). An increase in splice-redirecting
activity as the number of Arg residues is raised from 8 to 12
and 16 is not surprising, since the overall cell uptake for oligo-
Arg peptides of 5 to 8 residues was shown to increase as a
function of the number of Arg residues (32). However, the
number of Arg residues and the precise three-dimensional
conﬁguration within the peptide may also affect other steps in
the delivery to the nucleus. In general, we found that the longer
Figure 6. Luciferase activity of PNA705 conjugates of RXR6, RXR8, RXR8-4B1, or RXR8-2B using endocytosis inhibitors. Cells were preincubated
at 37 °C for 20 min with chlorpromazine (30 µM), methyl- -cyclodextrin (MBCD) (2.5 mM), nystatin (50 µM), or ammonium chloride (50 mM).
Cells were further incubated in the same conditions with the peptide conjugates at 1 µM for 30 min. Luciferase expression assays were carried out
after 24 h as indicated in the Experimental Procedures. Experiments were made in triplicate, and error bars are indicated. Data are expressed as the
percentage of luciferase activity.
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for the same total number of Arg residues. In the linear (R-
Ahx-R)4 peptide, we found previously that aminohexanoic acid
spacing between guanidinium groups was optimal for splice-
redirecting activity for an attached PMO oligonucleotide
compared to shorter or longer spacers (13). Further work will
be necessary to understand if this ﬁnding also holds true for
the branched peptides.
However, a differential level of overall cell uptake by linear
and branched peptides cannot be ruled out, especially since it
has been shown for ﬂuorescently labeled branched 8-Arg
peptides that they are more dependent on interaction with
membrane-associated heparan sulfate proteoglycans on the cell
surface compared to linear R8 peptides (22). Nevertheless, our
data are consistent with the notion that the active fraction of
branched Arg-rich peptide-PNAs does not use a different
pathway of uptake compared to the linear R-Ahx-R peptides.
This is evidenced by the very similar deleterious effects on
luciferase up-regulation activity seen upon lowering the tem-
perature of the splice correction assay to 4 °C and the similar
behavior upon coincubation with endocytosis inhibitors for both
branched and linear peptide-PNA constructs (Figures 5 and
6).
The very large effect of chlorpromazine on 16-Arg branched
and linear peptide-PNA conjugates (Figure 6) was similar to
the effects we previously observed in the same HeLa pLuc705
cells for other highly cationic peptide conjugates of PNA and
PMO, such as linear RXR4-PMO (11), Pip peptide-PNA (16),
and Tat peptide (15). We conclude as before that clathrin-
dependent uptake predominates. However, the effect of nystatin
on the luciferase up-regulation was much larger in the cases of
both linear and branched RXR-PNA conjugates compared to
the only small effects observed of nystatin on uptake and activity
of the Tat peptide (15) and on Pip-PNA (16). This surprising
result suggests that caveolae may play some part in uptake where
there are a larger number of Arg residues, as has already been
shown for Tat fusion proteins (33). This could account for the
moderate effect of NH4Cl in some cases, since caveolae-
mediated endocytosis does not involve acidic compartments
(34).
Our results are not entirely consistent with inhibitor experi-
ments in the same cell assay for PNA705 conjugates of mod-
erately cationic, Arg-containing peptides Penetratin and M918,
where macropinocystosis was suggested as the major uptake
pathway and clathrin-dependent endocytosis predominated only
for the more hydrophobic TP10-PNA conjugate (35). The
concentration of chlorpromazine used in our case was 30 µM,
whereas in the case of Lundin et al., it was only 10 µM, and
the peptide-PNA concentrations used in our case were 5-fold
lower. Poon et al. reported for R8-functionalized liposome uptake
that endocytotic uptake switches from clathrin-dependent to
macropinocytosis as peptide density on the liposome surface
was increased (36), and a mechanism switch is one possible
explanation for the discrepancy between our studies and those
of Lundin et al. Another possibility is that the choice of uptake
pathway is more subtly affected by the different relative po-
sitions of the hydrophobic and cationic elements in M918 and
Penetratin as compared to the R-Ahx-R constructs. The possible
sensitivity of inhibitor use to different cellular conditions, as well
as possible subtle effects of amino acid composition and position-
ing, makes it hard to draw too deﬁnitive conclusions about the
endocytosis pathways used by cationic CPPs in this class when
conjugated to PNA. Further, our result that MBCD addition
signiﬁcantly stimulated luciferase up-regulation suggests that, when
one pathway is inhibited, it is possible for cells to utilize or stimulate
an alternative uptake pathway. More sophisticated cell techniques
will be needed to clarify the dominant endocytotic uptake pathways
for particular peptide-cargo conjugates.
A major aim of our experiments was to determine whether
branched R-Ahx-R peptides could prove suitable for future
development in a therapeutic context. We were particularly
heartened that signiﬁcant splice-redirecting activity was retained
in the HeLa cell assay in the presence of 10% serum for many
of the 12-Arg and 16-Arg containing conjugates (Supporting
Information Figure 3), and we obtained extremely high exon
skipping for RXR8-2B-PMO in a mdx mouse muscle cell assay
that is used as a model for DMD (data not shown). However,
we became concerned about the possibility of increased toxicity
resulting from the use of larger numbers of Arg residues in the
peptides. Although we did not observe toxicity up to 3 µMi n
the HeLa pLuc705 cell assay (Figure 4), we did see signiﬁcant
loss of cell viability at 1 µM in A375SM-Luc705-B melanoma
cells for all 12 and 16 Arg conjugates (data not shown). Further,
a very recent report has suggested that at high doses in both
mice and monkeys some kidney toxicity is apparent when an
8-Arg peptide-PMO is injected intravenously (6). Thus, despite
the substantial increase in cell delivery potential afforded by
such dendrimeric peptide constructs, peptide conjugates with
high Arg content must be used with caution in therapeutic
development until the sources of these toxicities (both cellular
and in vivo) can be controlled. In the case of cells, more detailed
studies of membrane leakage or other speciﬁc cell toxicity assays
could prove instructive.
Nevertheless, our studies have been useful in understanding
some of the three-dimensional requirements for cell uptake and
splice-redirecting activity of Arg-rich peptides based on an
R-Ahx-R motif, and we have demonstrated that chain branching
is well-tolerated when the number of Arg residues is high,
especially for 2-branched peptide structures. We have shown
also how such peptide chain branching is readily accessible
chemically and in high yield. In principle, our methods could
be used also to introduce other multiple motifs such as cell-
speciﬁc uptake sequences (17) as conjugates of PNA or PMO
cargoes. Our work expands the three-dimensional space avail-
able for CPP development.
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